These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28751103)

  • 41. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S).
    Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG
    Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overactive Bladder Symptoms in Female Health Profession Students: Bladder Diary Characteristics and Impact of Symptoms on Health-Related Quality of Life.
    Reisch R; Rutt R; Dockter M; Sanders S
    J Womens Health (Larchmt); 2018 Feb; 27(2):156-161. PubMed ID: 28953429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Relationship Between Anxiety and Overactive Bladder or Urinary Incontinence Symptoms in the Clinical Population.
    Lai HH; Rawal A; Shen B; Vetter J
    Urology; 2016 Dec; 98():50-57. PubMed ID: 27450939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study.
    Vaughan CP; Johnson TM; Ala-Lipasti MA; Cartwright R; Tammela TL; Taari K; Auvinen A; Tikkinen KA
    Eur Urol; 2011 Apr; 59(4):629-36. PubMed ID: 21306820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
    Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
    J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overactive bladder: prevalence and implications in Brazil.
    Teloken C; Caraver F; Weber FA; Teloken PE; Moraes JF; Sogari PR; Graziottin TM
    Eur Urol; 2006 Jun; 49(6):1087-92. PubMed ID: 16497431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden.
    Peeker R; Samsioe G; Kowalski J; Andersson AS; Bergqvist A
    Scand J Urol Nephrol; 2010 Apr; 44(3):138-46. PubMed ID: 20367449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sleep Disturbance and Fatigue Are Associated With More Severe Urinary Incontinence and Overactive Bladder Symptoms.
    Ge TJ; Vetter J; Lai HH
    Urology; 2017 Nov; 109():67-73. PubMed ID: 28826875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychometric equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish.
    Coyne KS; Margolis MK; Thompson C; Kopp Z
    Value Health; 2008 Dec; 11(7):1096-101. PubMed ID: 18489500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of probable overactive bladder in a private obstetrics and gynecology group practice.
    Finkelstein K; Glosner S; Sanchez RJ; Uddin N
    Curr Med Res Opin; 2008 Apr; 24(4):1083-90. PubMed ID: 18328119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
    BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence, evaluation and management of overactive bladder in primary care.
    Cheung WW; Khan NH; Choi KK; Bluth MH; Vincent MT
    BMC Fam Pract; 2009 Jan; 10():8. PubMed ID: 19166611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association between the self-perception period of overactive bladder symptoms and overactive bladder symptom scores in a non-treated population and related sociodemographic and lifestyle factors.
    Kim JH; Ham BK; Shim SR; Lee WJ; Kim HJ; Kwon SS; Bae JH
    Int J Clin Pract; 2013 Aug; 67(8):795-800. PubMed ID: 23869680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.
    Milsom I; Kaplan SA; Coyne KS; Sexton CC; Kopp ZS
    Urology; 2012 Jul; 80(1):90-6. PubMed ID: 22748867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptom severity and patient perceptions in overactive bladder: how are they related?
    Homma Y; Gotoh M
    BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Burden of overactive bladder symptom on quality of life in stroke patients.
    Itoh Y; Yamada S; Konoeda F; Koizumi K; Nagata H; Oya M; Suzuki N
    Neurourol Urodyn; 2013 Jun; 32(5):428-34. PubMed ID: 23129306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of childhood and recent traumatic events on the clinical presentation of overactive bladder.
    Lai HH; Morgan CD; Vetter J; Andriole GL
    Neurourol Urodyn; 2016 Nov; 35(8):1017-1023. PubMed ID: 26332868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.